Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile

Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
41 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. It develops and markets antibodies and other related products. Its wide range of products includes antibody reagents, antigens and test-kits. Its major products include primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteins and peptides, proteomics tools, agonists, activators, antagonists and inhibitors, lysates, and multiplex miRNA assay.

Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal f

  
Source:
Document ID
GDME6523D
Country
Industry
Ticker
ABC=GB
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Abcam Plc, Medical Equipment, Deals By Year, 2010 to YTD 201652
Abcam Plc, Medical Equipment Deals By Type, 2010 to YTD 201671
Abcam Plc, Medical Equipment, Deals By Region, 2010 to YTD 201681
Abcam Plc, Medical Equipment, Deals By Market, 2010 to YTD 201691
Abcam Plc, Medical Equipment, Deals Summary, 2010 to YTD 2016101
Abcam Plc, Medical Equipment, Deal Details1111
  Venture Financing111
    Firefly BioWorks Raises USD0.8 Million in Venture Financing111
    Firefly BioWorks Secures US$2 Million In Series A Venture Financing121
  Partnerships131
    Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False Neurotransmitters131
    Abcam Enters into Agreement with Institute Of Molecular And Cell Biology141
    Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies151
    Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore161
    Dako Denmark Enters Into Co-Development Agreement With Epitomics171
  Equity Offering181
    Epitomics Withdraws IPO Of Common Stock181
  Acquisition191
    Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer191
    Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million201
    Abcam Acquires MitoSciences211
Abcam Plc - Key Competitors221
Key Employees231
Locations And Subsidiaries242
  Head Office241
  Other Locations &Subsidiaries242
Recent Developments261
Financial Announcements261
Sep 12, 2016: ABCAM: Strong revenue performance enabling investment for future growth264
Mar 07, 2016: Abcam delivers sustained double digit revenue growth whilst investing in the future301
Sep 14, 2015: ABCAM: Preliminary Results for the Year Ended 30 June 2015`314
Mar 09, 2015: Abcam: Interim Results for the Six Months Ended 31 December 2014351
Corporate Communications361
Jun 20, 2016: Abcam to appoint Gavin Wood, former Affymetrix executive, as Chief Financial Officer361
Mar 07, 2016: Abcam: Directorate Change371
Sep 14, 2015: ABCAM: Directorate Changes381
Jun 29, 2015: ABCAM Appoints Chief Legal Officer and Company Secretary391
Other Significant Developments401
Jul 25, 2016: Abcam: Pre-Close Period Update401
Appendix411
  Methodology411
  About GlobalData411
  Contact Us411
  Disclaimer411

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 04, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Abcam-Plc-ABC-Medical-Equipment-Deals-and-Alliances-Profile-2148-5644>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Abcam-Plc-ABC-Medical-Equipment-Deals-and-Alliances-Profile-2148-5644>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research